Cellyan Biotechnology (HKPD) Inventory (2024 - 2026)
Cellyan Biotechnology (HKPD) posted quarterly Inventory of $593373.0 for Q3 2025, up 6.81% year-over-year from $555522.0 in Q3 2024, and up 5.96% quarter-over-quarter from $559982.0 in Q1 2025.
Cellyan Biotechnology (HKPD) Inventory (2024 - 2026) Analysis & Trends
Cellyan Biotechnology (HKPD) has reported Inventory for 2 consecutive years, with $593373.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Inventory rose 6.81% year-over-year to $593373.0; the TTM figure through Sep 2025 stood at $593373.0 (up 6.81% YoY), while the FY2025 annual figure was $559982.0, down 40.0% from the prior year.
- Inventory grew to $593373.0 in Q3 2025 per HKPD's latest filing, from $559982.0 in the prior quarter.
- Across five years, Inventory topped out at $933299.0 in Q1 2024 and bottomed at $555522.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 101.82 Bn | 96.65 Bn | 3.69 Bn | 26.26 Bn |
| 2 | Cencora | 61.46 Bn | 58.65 Bn | 3.61 Bn | 21.03 Bn |
| 3 | Cardinal Health | 54.37 Bn | 49.52 Bn | 2.56 Bn | 17.30 Bn |
| 4 | Henry Schein | 10.03 Bn | 9.87 Bn | 1.10 Bn | 2.06 Bn |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - | 12.24 Mn |
| 6 | Edap Tms | 157.62 Mn | 136.08 Mn | 7.34 Mn | 8.71 Mn |
| 7 | Accendra Health | 97.02 Mn | 89.37 Mn | 263.41 Mn | 73.35 Mn |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn | 147.36 Mn |
| 9 | Cosmos Health | 13.12 Mn | 10.67 Mn | 1.51 Mn | 4.52 Mn |
| 10 | Cellyan Biotechnology | 6.62 Mn | 6.40 Mn | - | 360,107.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 360,107.00 |
| Sep 30, 2025 | 593,373.00 |
| Mar 31, 2025 | 559,982.00 |
| Sep 30, 2024 | 555,522.00 |
| Mar 31, 2024 | 933,299.00 |